BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 12235181)

  • 1. Omega-carboxyl variants of 7-ketocholesteryl esters are ligands for beta(2)-glycoprotein I and mediate antibody-dependent uptake of oxidized LDL by macrophages.
    Liu Q; Kobayashi K; Furukawa J; Inagaki J; Sakairi N; Iwado A; Yasuda T; Koike T; Voelker DR; Matsuura E
    J Lipid Res; 2002 Sep; 43(9):1486-95. PubMed ID: 12235181
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A specific ligand for beta(2)-glycoprotein I mediates autoantibody-dependent uptake of oxidized low density lipoprotein by macrophages.
    Kobayashi K; Matsuura E; Liu Q; Furukawa J; Kaihara K; Inagaki J; Atsumi T; Sakairi N; Yasuda T; Voelker DR; Koike T
    J Lipid Res; 2001 May; 42(5):697-709. PubMed ID: 11352976
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxidized low-density lipoprotein as a risk factor of thrombosis in antiphospholipid syndrome.
    Matsuura E; Kobayashi K; Koike T; Shoenfeld Y; Khamashta MA; Hughes GR
    Lupus; 2003; 12(7):550-4. PubMed ID: 12892397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atherogenic autoantigen: oxidized LDL complexes with beta2-glycoprotein I.
    Matsuura E; Kobayashia K; Koikeb T; Shoenfeld Y; Khamashta MA; Hughes GR
    Immunobiology; 2003; 207(1):17-22. PubMed ID: 12638898
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The ω-carboxyl group of 7-ketocholesteryl-9-carboxynonanoate mediates the binding of oxLDL to CD36 receptor and enhances caveolin-1 expression in macrophages.
    Li J; Yu C; Wang R; Xu J; Chi Y; Qin J; Liu Q
    Int J Biochem Cell Biol; 2017 Sep; 90():121-135. PubMed ID: 28789920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating oxidized LDL forms complexes with beta2-glycoprotein I: implication as an atherogenic autoantigen.
    Kobayashi K; Kishi M; Atsumi T; Bertolaccini ML; Makino H; Sakairi N; Yamamoto I; Yasuda T; Khamashta MA; Hughes GR; Koike T; Voelker DR; Matsuura E
    J Lipid Res; 2003 Apr; 44(4):716-26. PubMed ID: 12562869
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant domain V of β2-glycoprotein I inhibits the formation of atherogenic oxLDL/β2-glycoprotein I complexes.
    Li J; Chi Y; Liu S; Wang L; Wang R; Han X; Matsuura E; Liu Q
    J Clin Immunol; 2014 Aug; 34(6):669-76. PubMed ID: 24970589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-beta 2-glycoprotein I autoantibodies and atherosclerosis.
    Matsuura E; Kobayashi K; Kasahara J; Yasuda T; Makino H; Koike T; Shoenfeld Y
    Int Rev Immunol; 2002; 21(1):51-66. PubMed ID: 12187845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Binding of glycoprotein β₂-GPI with oxidized low density lipoprotein].
    Zhang H; Li J; Chen A; Liu Q
    Sheng Wu Gong Cheng Xue Bao; 2017 Jan; 33(1):122-131. PubMed ID: 28959869
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autoantibody-mediated atherosclerosis.
    Matsuura E; Kobayashi K; Koike T; Shoenfeld Y
    Autoimmun Rev; 2002 Dec; 1(6):348-53. PubMed ID: 12848990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recombinant domain V of β2-glycoprotein I inhibits the formation of a 7-ketocholesteryl-9-carboxynonanoate and β2-glycoprotein I complex.
    Zhang Y; Li W; Chi Y; Wang R; Wang D; Zhang F; Liu Z; Matsuura E; Liu Q
    J Biochem; 2011 Jan; 149(1):35-42. PubMed ID: 20876187
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The lipid moiety 7-ketocholesteryl-9-carboxynonanoate mediates binding interaction of oxLDL to LOX-1 and upregulates ABCA1 expression through PPARγ.
    Li J; Xiu Z; Wang R; Yu C; Chi Y; Qin J; Fu C; Matsuura E; Liu Q
    Life Sci; 2017 May; 177():27-40. PubMed ID: 28377266
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Free and esterified oxysterol: formation during copper-oxidation of low density lipoprotein and uptake by macrophages.
    Brown AJ; Dean RT; Jessup W
    J Lipid Res; 1996 Feb; 37(2):320-35. PubMed ID: 9026530
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 7-ketocholesteryl-9-carboxynonanoate induced nuclear factor-kappa B activation in J774A.1 macrophages.
    Huang Z; Li W; Wang R; Zhang F; Chi Y; Wang D; Liu Z; Zhang Y; Matsuura E; Liu Q
    Life Sci; 2010 Nov; 87(19-22):651-7. PubMed ID: 20932850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intracellular trafficking of beta2-glycoprotein I complexes with lipid vesicles in macrophages: implications on the development of antiphospholipid syndrome.
    Kajiwara T; Yasuda T; Matsuura E
    J Autoimmun; 2007; 29(2-3):164-73. PubMed ID: 17826950
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibodies against beta2-glycoprotein I complexed with an oxidised lipoprotein relate to intima thickening of carotid arteries in primary antiphospholipid syndrome.
    Ames PR; Delgado Alves J; Lopez LR; Gentile F; Margarita A; Pizzella L; Batuca J; Scenna G; Brancaccio V; Matsuura E
    Clin Dev Immunol; 2006 Mar; 13(1):1-9. PubMed ID: 16603439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cholesterol and oxysterol metabolism and subcellular distribution in macrophage foam cells. Accumulation of oxidized esters in lysosomes.
    Brown AJ; Mander EL; Gelissen IC; Kritharides L; Dean RT; Jessup W
    J Lipid Res; 2000 Feb; 41(2):226-37. PubMed ID: 10681406
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Involvement of beta 2-glycoprotein I and anticardiolipin antibodies in oxidatively modified low-density lipoprotein uptake by macrophages.
    Hasunuma Y; Matsuura E; Makita Z; Katahira T; Nishi S; Koike T
    Clin Exp Immunol; 1997 Mar; 107(3):569-73. PubMed ID: 9067534
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oxidized low-density lipoprotein/beta2-glycoprotein I complexes and autoantibodies to oxLig-1/beta2-glycoprotein I in patients with systemic lupus erythematosus and antiphospholipid syndrome.
    Lopez D; Garcia-Valladares I; Palafox-Sanchez CA; De La Torre IG; Kobayashi K; Matsuura E; Lopez LR
    Am J Clin Pathol; 2004 Mar; 121(3):426-36. PubMed ID: 15023048
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distinguished effects of antiphospholipid antibodies and anti-oxidized LDL antibodies on oxidized LDL uptake by macrophages.
    Kobayashi K; Tada K; Itabe H; Ueno T; Liu PH; Tsutsumi A; Kuwana M; Yasuda T; Shoenfeld Y; de Groot PG; Matsuura E
    Lupus; 2007; 16(12):929-38. PubMed ID: 18042586
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.